![]() |
Volumn 37, Issue 4, 2005, Pages 1697-1699
|
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
TACROLIMUS;
ACUTE GRAFT REJECTION;
ADULT;
ANEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DIABETES MELLITUS;
DIARRHEA;
DRUG EFFICACY;
DRUG SAFETY;
DYSPEPSIA;
FEMALE;
FOLLOW UP;
GASTRITIS;
GASTROINTESTINAL TOXICITY;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
LEUKOPENIA;
LIVER TRANSPLANTATION;
MALE;
MORBIDITY;
NAUSEA;
NEPHROTOXICITY;
NEUROTOXICITY;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL ANALYSIS;
TREATMENT OUTCOME;
VOMITING;
ACUTE DISEASE;
ADRENAL CORTEX HORMONES;
ADULT;
AREA UNDER CURVE;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGED;
MYCOPHENOLIC ACID;
POSTOPERATIVE PERIOD;
SURVIVAL ANALYSIS;
TACROLIMUS;
|
EID: 20344366568
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2005.02.111 Document Type: Conference Paper |
Times cited : (18)
|
References (4)
|